Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes

Clinical trial NCT00102687 · COMPLETED

Trial details

NCT number: NCT00102687
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2005-01-01
Primary completion: 2008-08-01
Enrollment: 151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.